1. Home
  2. HUMA vs CPSS Comparison

HUMA vs CPSS Comparison

Compare HUMA & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • CPSS
  • Stock Information
  • Founded
  • HUMA 2004
  • CPSS 1991
  • Country
  • HUMA United States
  • CPSS United States
  • Employees
  • HUMA N/A
  • CPSS N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • CPSS Finance: Consumer Services
  • Sector
  • HUMA Health Care
  • CPSS Finance
  • Exchange
  • HUMA Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • HUMA 221.8M
  • CPSS 193.8M
  • IPO Year
  • HUMA N/A
  • CPSS 1992
  • Fundamental
  • Price
  • HUMA $2.67
  • CPSS $9.05
  • Analyst Decision
  • HUMA Strong Buy
  • CPSS
  • Analyst Count
  • HUMA 7
  • CPSS 0
  • Target Price
  • HUMA $13.00
  • CPSS N/A
  • AVG Volume (30 Days)
  • HUMA 5.4M
  • CPSS 12.5K
  • Earning Date
  • HUMA 05-13-2025
  • CPSS 05-12-2025
  • Dividend Yield
  • HUMA N/A
  • CPSS N/A
  • EPS Growth
  • HUMA N/A
  • CPSS N/A
  • EPS
  • HUMA N/A
  • CPSS 0.79
  • Revenue
  • HUMA $517,000.00
  • CPSS $188,776,000.00
  • Revenue This Year
  • HUMA N/A
  • CPSS $146.82
  • Revenue Next Year
  • HUMA $896.45
  • CPSS $18.24
  • P/E Ratio
  • HUMA N/A
  • CPSS $11.45
  • Revenue Growth
  • HUMA N/A
  • CPSS N/A
  • 52 Week Low
  • HUMA $1.15
  • CPSS $7.85
  • 52 Week High
  • HUMA $9.97
  • CPSS $12.73
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 69.67
  • CPSS 50.84
  • Support Level
  • HUMA $2.41
  • CPSS $8.68
  • Resistance Level
  • HUMA $2.88
  • CPSS $8.99
  • Average True Range (ATR)
  • HUMA 0.30
  • CPSS 0.31
  • MACD
  • HUMA 0.10
  • CPSS -0.01
  • Stochastic Oscillator
  • HUMA 87.43
  • CPSS 34.03

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: